Archive | March, 2026

Congratulations to Cyabra, Inc. (CYAB) on its successful business combination and listing on The Nasdaq Stock Market!

Leave a comment Continue Reading →

Congratulations to Advanced Biomed Inc. on regaining compliance with all requirements for continued listing on The Nasdaq Capital Market!

Leave a comment Continue Reading →

Congratulations to Agape ATP Corporation on regaining compliance with all requirements for continued listing on The Nasdaq Capital Market!

Leave a comment Continue Reading →

Proposed Nasdaq Rule Would Trigger Immediate Suspension Following 30 Business Days Below $5M Market Cap – Advance Action Required to Avoid Immediate Trading Suspension & Delisting Following Adoption of the Rule

Dear Nasdaq Issuer, Nasdaq has proposed to adopt a new continued listing standard requiring a minimum market value of listed securities (“MVLS”) of $5M, notwithstanding an issuer’s compliance with all other continued listing criteria. If the proposed rule is approved – with effectiveness as early as March 16, 2026 – any Nasdaq-listed issuer with a closing […]

Leave a comment Continue Reading →

Congratulations to Noodles & Company on regaining compliance with all requirements for continued listing on The Nasdaq Global Select Market!

Leave a comment Continue Reading →

Congratulations to Co-Diagnostics, Inc. on its successful reinstatement on The Nasdaq Stock Market after regaining compliance with all requirements for continued listing!

Leave a comment Continue Reading →

Congratulations to urban-gro, Inc. on regaining compliance with all requirements for continued listing on The Nasdaq Capital Market!

Leave a comment Continue Reading →

Congratulations to Intensity Therapeutics on regaining compliance with the Nasdaq continued listing criteria!

Leave a comment Continue Reading →

Congratulations to Orangekloud Technology Inc. on regaining compliance with all requirements for continued listing on The Nasdaq Capital Market!

Leave a comment Continue Reading →

Congratulations to RallyBio on its compliance with all Nasdaq continued listing criteria!

Leave a comment Continue Reading →